Myxoid liposarcoma with transition to round-cell lesion cell cycle regulator genes and telomerase activity characterizing tumor progression: A case report

Human Pathology

Volumn 30, Issue 12, 1999, Pages 1515-1519

  Jaeger, V ^a   Schneider Stock, R ^b   Gerresheim, F ^b   Epplen, J T ^b   Serra, M ^b   Lippert, H ^b   Roessner, A ^b  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b NONE

Author keywords

c myc expression; Myxoid liposarcoma; Telomerase activity

Indexed keywords

MESSENGER RNA; MONOCLONAL ANTIBODY KI 67; MYC PROTEIN; TELOMERASE;

ADULT; ARTICLE; CASE REPORT; CELL CYCLE; CELL PROLIFERATION; CHROMOSOME 16; CHROMOSOME TRANSLOCATION 12; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MYXOSARCOMA; ONCOGENE C MYC; PROTEIN EXPRESSION; REGULATOR GENE; TUMOR GROWTH;

EID: 0033427617     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(99)90176-4     Document Type: Article

References (18)

1. Enzinger FM, Weiss SW (eds): Soft tissue tumors (ed 3). St Louis, MO, CV Mosby, 1995, pp 431-466
2. Crozat A, Aman P, Mandahl N, et al: Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature 363:640-644, 1993
3. Mentzel T, Fletcher CDM: Lipomatous tumours of soft tissues: An update. Virchows Arch 427:353-363, 1995
4. Dei Tos AP, Doglioni C, Piccinin S, et al: Molecular abnormalities of the p53 pathway in dedifferentiated liposarcoma. J Pathol 181:8-13, 1997
5. Dei Tos AP, Piccinin S, Doglioni C, et al: Molecular aberrations of the G1-S checkpoint in myxoid and round cell liposarcoma. Am J Pathol 151:1531-1539, 1997
6. Pilotti S, Della Torre G, Lavarino C, et al: Distinct mdm2/p53 expression patterns in liposarcoma subgroups: implications for different pathogenetic mechanisms. J Pathol 181:14-24, 1997
7. Schneider-Stock R, Walter H, Rys J, et al: No correlation of c-myc overexpression and p53 mutations in liposarcomas. Virchows Arch 433:315-321, 1998
8. Schneider-Stock R, Walter H, Radig K, et al: MDM2 amplification and loss of heterozygosity at Rb and p53 genes: No simultaneous alterations in the oncogenesis of liposarcomas. J Cancer Res Clin Oncol 124:532-540, 1998
9. Kim NW, Piatyszek MA, Prowse KR: Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011-2015, 1994
10. Schneider-Stock R, Epplen JT, Walter H, et al: Telomeric lengths and telomerase activity in liposarcomas. Mol Carcinogen 24:144-151, 1999
11. Sambrook J, Fritzsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, New York, Cold Spring Harbor Laboratory Press, 1989
12. Schneider-Stock R, Radig K, Oda Y, et al: P53 gene mutations in soft-tissue sarcomas-correlations with p53 immunohistochemistry and DNA ploidy. J Cancer Res Clin Oncol 123:211-218, 1997
13. Midelman F, ed: ISCN: An international system of human cytogenetic nomenclature. Basel, Switzerland, S. Karger, 1985
14. Schneider-Stock R, Rys J, Walter H, et al: A rare chimeric TLS/FUS-CHOP transcript in a patient with multiple liposarcomas: A case report. Cancer Genet Cytogenet 111: 1-4, 1999
15. Knight JC, Renwick PJ, Dal Cin P, et al: Translocation t(12;16) (q13;p11) in myxoid liposarcoma and round cell liposarcoma: Molecular and cytogenetic analysis. Cancer Res 55:24-27, 1995
16. Sato K, Miyahara M, Saito T, et al: C-myc mKNA overexpression is associated with lymph node metastasis in colorectal cancer. Eur J Cancer 30:1113-1117, 1994
17. Finley GC, Schulz NT, Hill SA, et al: Expression of the myc gene family in different stages of human colorectal cancer. Oncogene 4:963-971, 1989
18. Isfort RJ, Cody DB, Lovell G, et al: Analysis of oncogenes, tumor suppressor genes, autocrine growth factor production, and differentiation state of human osteosarcoma cell lines. Mol Carcinog 14:170-178, 1995